Regulatory UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention PharmaTimesClesrovimab is first monoclonal antibody offering a single fixed dose for infantsInfectious DiseaseRead full story pharminent April 27, 2026 (Last updated: April 27, 2026) PharmaTimes Clesrovimab is first monoclonal antibody offering a single fixed dose for infants Infectious Disease Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Sun Pharma to acquire Organon for $11.75bnNext: UK biotech could be bound for recovery, BIA report reveals Related Stories Regulatory FDA delays verdict on AZ breast cancer drug pharminent May 27, 2026 Regulatory Pierre Fabre’s Braftovi gains CHMP positive opinion for mCRC pharminent May 26, 2026 Regulatory Bayer gets swift review for Kerendia in type 1 diabetes pharminent May 21, 2026
